Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Retained Earnings: 2019-2024

Historic Retained Earnings for CureVac N.V (CVAC) over the last 6 years, with Dec 2024 value amounting to -$1.5 billion.

  • CureVac N.V's Retained Earnings rose 6.80% to -$1.7 billion in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.7 billion, marking a year-over-year increase of 6.80%. This contributed to the annual value of -$1.5 billion for FY2024, which is 10.97% up from last year.
  • Per CureVac N.V's latest filing, its Retained Earnings stood at -$1.5 billion for FY2024, which was up 10.97% from -$1.7 billion recorded in FY2023.
  • CureVac N.V's 5-year Retained Earnings high stood at -$769.1 million for FY2020, and its period low was -$1.7 billion during FY2023.
  • Moreover, its 3-year median value for Retained Earnings was -$1.5 billion (2024), whereas its average is -$1.5 billion.
  • In the last 5 years, CureVac N.V's Retained Earnings plummeted by 57.19% in 2021 and then increased by 10.97% in 2024.
  • Yearly analysis of 5 years shows CureVac N.V's Retained Earnings stood at -$769.1 million in 2020, then crashed by 57.19% to -$1.2 billion in 2021, then declined by 10.20% to -$1.3 billion in 2022, then decreased by 26.47% to -$1.7 billion in 2023, then grew by 10.97% to -$1.5 billion in 2024.